» Articles » PMID: 37629427

Effect of Obesity on Lung Function in the Pediatric and Adult Populations with Asthma: A Review

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Aug 26
PMID 37629427
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and asthma are major global health concerns, particularly in industrialized nations. Obesity has been shown to have detrimental effects on the respiratory system and lung function owing to metabolic issues and immunological consequences. Research has indicated that obese patients with asthma (atopic or T2-high and non-atopic or T2-low) have diminished lung function in terms of functional residual capacity (FRC), residual volume (RV), expiratory reserve volume (ERV), the FEV1/FVC ratio, and FEF 25-75% due to mechanical fat loading on the diaphragm and central adiposity when compared to non-obese asthmatic patients. Therefore, it is plausible that changes in lung function are the result of a combination of mechanical (fat loading on the diaphragm, central adiposity, bronchial hyper-reactivity, and an increase in cholinergic tone), environmental (diet and exercise), and inflammatory factors (local and systemic), which can lead to the obesity-related asthma phenotype characterized by severe asthma symptoms, poor response to corticosteroid treatment, loss of lung function, and poor quality of life from an early age.

Citing Articles

Associations between metabolic score for visceral fat and adult lung functions from NHANES 2007-2012.

Zhou J, You L, Zhou X, Li Y Front Nutr. 2024; 11:1436652.

PMID: 39659905 PMC: 11628286. DOI: 10.3389/fnut.2024.1436652.


Association between Serum Lipids and Asthma in Adults-A Systematic Review.

Mastaleru A, Popescu G, Abdulan I, Cumpat C, Costache A, Grosu C Nutrients. 2024; 16(13).

PMID: 38999820 PMC: 11243052. DOI: 10.3390/nu16132070.


Roles of gender and smoking in the associations between urinary phytoestrogens and asthma/wheeze and lung function: evidence from a cross-sectional study.

Zhang Y, Huang T, Wang J, Wang G, Luo F BMJ Open Respir Res. 2024; 11(1).

PMID: 38448045 PMC: 10916099. DOI: 10.1136/bmjresp-2023-001708.

References
1.
Huang Y, Nariya S, Harris J, Lynch S, Choy D, Arron J . The airway microbiome in patients with severe asthma: Associations with disease features and severity. J Allergy Clin Immunol. 2015; 136(4):874-84. PMC: 4600429. DOI: 10.1016/j.jaci.2015.05.044. View

2.
Hellinckx J, De Boeck K, van der Poel M, Demedts M . Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children. Eur Respir J. 1998; 12(2):438-43. DOI: 10.1183/09031936.98.12020438. View

3.
Foer D, Beeler P, Cui J, Karlson E, Bates D, Cahill K . Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists. Am J Respir Crit Care Med. 2020; 203(7):831-840. PMC: 8017590. DOI: 10.1164/rccm.202004-0993OC. View

4.
de Oliveira Jorge P, de Lima J, Chong E Silva D, Medeiros D, Sole D, Wandalsen G . Impulse oscillometry in the assessment of children's lung function. Allergol Immunopathol (Madr). 2018; 47(3):295-302. DOI: 10.1016/j.aller.2018.03.003. View

5.
Zein J, Erzurum S . Asthma is Different in Women. Curr Allergy Asthma Rep. 2015; 15(6):28. PMC: 4572514. DOI: 10.1007/s11882-015-0528-y. View